Phosphodiesterase 2 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Phosphodiesterase 2" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

18doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1rcsb.org

8,838^th place

8,783^rd place

1gla.ac.uk

2,948^th place

1,879^th place

1ubi.pt

low place

1aspetjournals.org

6,663^rd place

5,792^nd place

1sav.sk

low place

1handle.net

102^nd place

76^th place

aspetjournals.org

jpet.aspetjournals.org

Haynes J, Killilea DW, Peterson PD, Thompson WJ (February 1996). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung". J. Pharmacol. Exp. Ther. 276 (2): 752–7. doi:10.1016/S0022-3565(25)12354-9. PMID 8632346.

doi.org

Iffland A, Kohls D, Low S, et al. (June 2005). "Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system". Biochemistry. 44 (23): 8312–25. doi:10.1021/bi047313h. PMID 15938621.
Martinez SE, Wu AY, Glavas NA, et al. (October 2002). "The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding". Proc. Natl. Acad. Sci. U.S.A. 99 (20): 13260–5. Bibcode:2002PNAS...9913260M. doi:10.1073/pnas.192374899. PMC 130621. PMID 12271124.
Bender AT, Beavo JA (September 2006). "Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use". Pharmacol. Rev. 58 (3): 488–520. doi:10.1124/pr.58.3.5. PMID 16968949. S2CID 7397281.
Card GL, England BP, Suzuki Y, et al. (December 2004). "Structural basis for the activity of drugs that inhibit phosphodiesterases". Structure. 12 (12): 2233–47. doi:10.1016/j.str.2004.10.004. PMID 15576036.
Zhang KY, Card GL, Suzuki Y, et al. (July 2004). "A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases". Mol. Cell. 15 (2): 279–86. doi:10.1016/j.molcel.2004.07.005. PMID 15260978.
Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (September 2004). "Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A". J. Biol. Chem. 279 (36): 37928–38. doi:10.1074/jbc.M404287200. PMID 15210692.
Kass DA (2013). "Et Tu PDE2?". J Am Coll Cardiol. 62 (17): 1607–1609. doi:10.1016/j.jacc.2013.06.003. PMID 23810892.
Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M (2011). "cGMP signals modulate camp levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes". Circ Res. 108 (8): 929–939. doi:10.1161/CIRCRESAHA.110.230698. PMC 3083836. PMID 21330599.
Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton GM; Lefkimmiatis K; Sjaastad I; Zaccolo M (2015). "Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2" (PDF). Circ Res. 117 (8): 707–719. doi:10.1161/CIRCRESAHA.114.305892. PMID 26243800.
Podzuweit T, Nennstiel P, Müller A (September 1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell. Signal. 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
Suvarna NU, O'Donnell JM (July 2002). "Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus". J. Pharmacol. Exp. Ther. 302 (1): 249–56. doi:10.1124/jpet.302.1.249. PMID 12065724.
Boess FG, Hendrix M, van der Staay FJ, et al. (December 2004). "Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance". Neuropharmacology. 47 (7): 1081–92. doi:10.1016/j.neuropharm.2004.07.040. PMID 15555642. S2CID 25756665.
van Calker D, Müller M, Hamprecht B (1978). "Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells". Nature. 276 (5690): 839–41. Bibcode:1978Natur.276..839C. doi:10.1038/276839a0. PMID 214714. S2CID 4272425.
Rivet-Bastide M, Vandecasteele G, Hatem S, et al. (June 1997). "cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes" (PDF). J. Clin. Invest. 99 (11): 2710–8. doi:10.1172/JCI119460. PMC 508117. PMID 9169501.
Haynes J, Killilea DW, Peterson PD, Thompson WJ (February 1996). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung". J. Pharmacol. Exp. Ther. 276 (2): 752–7. doi:10.1016/S0022-3565(25)12354-9. PMID 8632346.
Chambers RJ, Abrams K, Garceau NY, et al. (January 2006). "A new chemical tool for exploring the physiological function of the PDE2 isozyme". Bioorg. Med. Chem. Lett. 16 (2): 307–10. doi:10.1016/j.bmcl.2005.10.005. PMID 16275071.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R (2007). "Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium". Pharmacol Res. 56 (2): 124–131. doi:10.1016/j.phrs.2007.04.017. hdl:2437/161968. PMID 17574432.
Seybold J, Thomas D, Witzenrath M, et al. (May 2005). "Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability". Blood. 105 (9): 3569–76. doi:10.1182/blood-2004-07-2729. PMID 15650061.

gla.ac.uk

eprints.gla.ac.uk

Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton GM; Lefkimmiatis K; Sjaastad I; Zaccolo M (2015). "Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2" (PDF). Circ Res. 117 (8): 707–719. doi:10.1161/CIRCRESAHA.114.305892. PMID 26243800.

handle.net

hdl.handle.net

Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R (2007). "Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium". Pharmacol Res. 56 (2): 124–131. doi:10.1016/j.phrs.2007.04.017. hdl:2437/161968. PMID 17574432.

harvard.edu

ui.adsabs.harvard.edu

Martinez SE, Wu AY, Glavas NA, et al. (October 2002). "The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding". Proc. Natl. Acad. Sci. U.S.A. 99 (20): 13260–5. Bibcode:2002PNAS...9913260M. doi:10.1073/pnas.192374899. PMC 130621. PMID 12271124.
van Calker D, Müller M, Hamprecht B (1978). "Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells". Nature. 276 (5690): 839–41. Bibcode:1978Natur.276..839C. doi:10.1038/276839a0. PMID 214714. S2CID 4272425.

nih.gov

pubmed.ncbi.nlm.nih.gov

Iffland A, Kohls D, Low S, et al. (June 2005). "Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system". Biochemistry. 44 (23): 8312–25. doi:10.1021/bi047313h. PMID 15938621.
Martinez SE, Wu AY, Glavas NA, et al. (October 2002). "The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding". Proc. Natl. Acad. Sci. U.S.A. 99 (20): 13260–5. Bibcode:2002PNAS...9913260M. doi:10.1073/pnas.192374899. PMC 130621. PMID 12271124.
Bender AT, Beavo JA (September 2006). "Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use". Pharmacol. Rev. 58 (3): 488–520. doi:10.1124/pr.58.3.5. PMID 16968949. S2CID 7397281.
Card GL, England BP, Suzuki Y, et al. (December 2004). "Structural basis for the activity of drugs that inhibit phosphodiesterases". Structure. 12 (12): 2233–47. doi:10.1016/j.str.2004.10.004. PMID 15576036.
Zhang KY, Card GL, Suzuki Y, et al. (July 2004). "A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases". Mol. Cell. 15 (2): 279–86. doi:10.1016/j.molcel.2004.07.005. PMID 15260978.
Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (September 2004). "Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A". J. Biol. Chem. 279 (36): 37928–38. doi:10.1074/jbc.M404287200. PMID 15210692.
Kass DA (2013). "Et Tu PDE2?". J Am Coll Cardiol. 62 (17): 1607–1609. doi:10.1016/j.jacc.2013.06.003. PMID 23810892.
Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M (2011). "cGMP signals modulate camp levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes". Circ Res. 108 (8): 929–939. doi:10.1161/CIRCRESAHA.110.230698. PMC 3083836. PMID 21330599.
Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton GM; Lefkimmiatis K; Sjaastad I; Zaccolo M (2015). "Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2" (PDF). Circ Res. 117 (8): 707–719. doi:10.1161/CIRCRESAHA.114.305892. PMID 26243800.
Podzuweit T, Nennstiel P, Müller A (September 1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell. Signal. 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
Suvarna NU, O'Donnell JM (July 2002). "Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus". J. Pharmacol. Exp. Ther. 302 (1): 249–56. doi:10.1124/jpet.302.1.249. PMID 12065724.
Boess FG, Hendrix M, van der Staay FJ, et al. (December 2004). "Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance". Neuropharmacology. 47 (7): 1081–92. doi:10.1016/j.neuropharm.2004.07.040. PMID 15555642. S2CID 25756665.
van Calker D, Müller M, Hamprecht B (1978). "Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells". Nature. 276 (5690): 839–41. Bibcode:1978Natur.276..839C. doi:10.1038/276839a0. PMID 214714. S2CID 4272425.
Goldberg ND, Haddox MK, Nicol SE, et al. (1975). "Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis". Adv Cyclic Nucleotide Res. 5: 307–30. PMID 165672.
Rivet-Bastide M, Vandecasteele G, Hatem S, et al. (June 1997). "cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes" (PDF). J. Clin. Invest. 99 (11): 2710–8. doi:10.1172/JCI119460. PMC 508117. PMID 9169501.
Haynes J, Killilea DW, Peterson PD, Thompson WJ (February 1996). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung". J. Pharmacol. Exp. Ther. 276 (2): 752–7. doi:10.1016/S0022-3565(25)12354-9. PMID 8632346.
Chambers RJ, Abrams K, Garceau NY, et al. (January 2006). "A new chemical tool for exploring the physiological function of the PDE2 isozyme". Bioorg. Med. Chem. Lett. 16 (2): 307–10. doi:10.1016/j.bmcl.2005.10.005. PMID 16275071.
Gesztelyi R; Zsuga J; Hajdu P; Szabo JZ; Cseppento A; Szentmiklosi AJ (2003). "Positive inotropic effect of the inhibition of cyclic GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase (PDE2) on guinea pig left atria in eu- and hyperthyroidism" (PDF). Gen Physiol Biophys. 22 (4): 501–513. PMID 15113122.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R (2007). "Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium". Pharmacol Res. 56 (2): 124–131. doi:10.1016/j.phrs.2007.04.017. hdl:2437/161968. PMID 17574432.
Seybold J, Thomas D, Witzenrath M, et al. (May 2005). "Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability". Blood. 105 (9): 3569–76. doi:10.1182/blood-2004-07-2729. PMID 15650061.

ncbi.nlm.nih.gov

Martinez SE, Wu AY, Glavas NA, et al. (October 2002). "The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding". Proc. Natl. Acad. Sci. U.S.A. 99 (20): 13260–5. Bibcode:2002PNAS...9913260M. doi:10.1073/pnas.192374899. PMC 130621. PMID 12271124.
Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M (2011). "cGMP signals modulate camp levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes". Circ Res. 108 (8): 929–939. doi:10.1161/CIRCRESAHA.110.230698. PMC 3083836. PMID 21330599.
Rivet-Bastide M, Vandecasteele G, Hatem S, et al. (June 1997). "cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes" (PDF). J. Clin. Invest. 99 (11): 2710–8. doi:10.1172/JCI119460. PMC 508117. PMID 9169501.

rcsb.org

PDB: 1Z1L

sav.sk

gpb.sav.sk

Gesztelyi R; Zsuga J; Hajdu P; Szabo JZ; Cseppento A; Szentmiklosi AJ (2003). "Positive inotropic effect of the inhibition of cyclic GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase (PDE2) on guinea pig left atria in eu- and hyperthyroidism" (PDF). Gen Physiol Biophys. 22 (4): 501–513. PMID 15113122.

semanticscholar.org

api.semanticscholar.org

Bender AT, Beavo JA (September 2006). "Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use". Pharmacol. Rev. 58 (3): 488–520. doi:10.1124/pr.58.3.5. PMID 16968949. S2CID 7397281.
Boess FG, Hendrix M, van der Staay FJ, et al. (December 2004). "Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance". Neuropharmacology. 47 (7): 1081–92. doi:10.1016/j.neuropharm.2004.07.040. PMID 15555642. S2CID 25756665.
van Calker D, Müller M, Hamprecht B (1978). "Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells". Nature. 276 (5690): 839–41. Bibcode:1978Natur.276..839C. doi:10.1038/276839a0. PMID 214714. S2CID 4272425.

ubi.pt

ubibliorum.ubi.pt

Rivet-Bastide M, Vandecasteele G, Hatem S, et al. (June 1997). "cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes" (PDF). J. Clin. Invest. 99 (11): 2710–8. doi:10.1172/JCI119460. PMC 508117. PMID 9169501.